Item

Efficacy and safety in the KEYNOTE-966 study of pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC): impact of hepatitis B virus (HBV) infection

Yau, T.
; 
Chan, S. L.
; 
Kelley, R. K.
; 
Finn, R. S.
; 
Yoo, C.
; 
Furuse, J.
; 
Ren, Z.
; 
Klumpen, H. J.
; 
Ozaka, M.
; 
Pelzer, U.
... show 10 more
Citations
Google Scholar:
Lookup
Altmetric:
Abstract
Authors
Yau, T.
Chan, S. L.
Kelley, R. K.
Finn, R. S.
Yoo, C.
Furuse, J.
Ren, Z.
Klumpen, H. J.
Ozaka, M.
Pelzer, U.
Arslan, C.
Park, J. O.
Edeline, J.
Valle, J. W.
Ueno, M.
Vogel, A.
Starkopf, L.
Malhotra, U.
Siegel, A. B.
Qin, S.
Affiliation
Univ Hong Kong, Med, Hong Kong, Peoples R China Chinese Univ Hong Kong, Sir Yue Kong Pao Ctr, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R China Univ Calif San Francisco, Med Hematol Oncol, San Francisco, CA 94143 USA Univ Calif Los Angeles, Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA USA Univ Ulsan, Asan Med Ctr, Oncol, Coll Med, Seoul, South Korea Kyorin Univ Hosp, Gastroentel, Tokyo, Japan Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan Fudan Univ, Zhongshan Hosp, Hepat Oncol, Shanghai, Peoples R China Univ Amsterdam, Med Oncol, Med Ctr, Amsterdam, Netherlands Japanese Fdn Canc Res JFCR, Canc Inst Hosp, Gastroenterol, Tokyo, Japan Humboldt Univ, Freie Univ Berlin, Charite Campus Mitte, Dept Hematol Oncol & Canc Immunol,Berlin Inst Hlt, Berlin, Germany Izmir Econ Univ, Med Oncol, Med Point Hosp, Izmir, Turkiye Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea Ctr Eugene Marquis, Med Oncol, Rennes, France Univ Manchester, Div Canc Sci, Manchester, Lancs, England Cholangiocarcinoma Fdn, Salt Lake City, UT USA Kanagawa Canc Ctr, Gasteroenterol, Yokohama, Kanagawa, Japan Hannover Med Sch, Hepatol Oncol, Hannover, Germany Merck & Co Inc, Med Oncol, Rahway, NJ USA Peoples Liberat Army, Ctr Canc, Med Oncol, Nanjing, Peoples R China
Description
Date
2024
Publisher
Collections
All Paterson Institute for Cancer Research
Show all metadata
Keywords
Type
Article
Citation
Yau T, Chan SL, Kelley RK, Finn RS, Yoo C, Furuse J, et al. Efficacy and safety in the KEYNOTE-966 study of pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC): Impact of hepatitis B virus (HBV) infection. ANNALS OF ONCOLOGY. 2024 DEC;35:S1462-S. PubMed PMID: WOS:001401985200139. English.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627682
Embedded videos